Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Nl healthcare oct 24 - oct 30, 2015


Published on

Gyan Research weekly newsletter on #healthcare sector

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

Nl healthcare oct 24 - oct 30, 2015

  1. 1. Policy News  HP receives funds for trauma care facilities The central government has sanctioned INR 17 crore to upgrade and strengthen trauma care facilities in several government hospitals in Himachal Pradesh (HP). The funds were part of the centrally sponsored "capacity development for developing trauma care facilities in government hospitals located on national highways" scheme. Of the total amount, INR 6.075 crore has been sanctioned for Dr. Rajendra Prasad Government Medical Hospital in Kangra, INR 2.754 crore each for four trauma care facilities to be located at the zonal hospital in Mandi for Level III Trauma Care, the District Hospital in Chamba and the regional hospitals in Rampur, Hamirpur, Shimla.  Maharashtra sells Ayurvedic medicines, herbal products The Maharashtra government has launched the sale of Ayurvedic medicines and herbal products. Under the Van Dhan Jan Dhan Scheme, the state government’s shop in Nagpur is selling products derived from forests. The shop has already sold medication worth over INR 2 lakh within 25 days of its commencement. Two similar shops, covering 300 sq. ft. of area, have been planned at every railway station and at every airport across the state, where products such as Alovera powder, Amla powder and Nutgrass powder, among others, will be available. This initiative taps into the traditional knowledge of various kinds of plants to be used as medicine among the tribal. By using their in depth understanding of Ayurveda, the move will create employment for the forest people. To study forest products in each district, the government will hire a consulting firm.  Mandatory marketing code for pharma companies The central government is preparing a uniform code of conduct for the marketing of pharmaceutical products; the practice has been voluntary till date. Pharma companies will have to pay huge penalties for unethical and illegal marketing practices such as offering gifts, freebies and foreign trips to doctors in order to push sales. The draft will include specific penalties and punishment details for non-compliance. The Department of Pharmaceuticals (DoP) is preparing the draft, which will be placed in the public domain by November-end this year. Industry News  Large haul of Codeine syrup in Maharashtra The Maharashtra Food and Drug Administration (FDA) has busted a large illegal codeine racket. Around 15,000 bottles of illegal codeine cough syrup were seized from a godown in Mira-Bhayandar, where they were stored for sale in the black market in Mira Road. The cough syrup is a powerful intoxicant and is consumed mostly by youngsters as a drug. © Gyan Research and Analytics Pvt. Ltd., 2015 1 Healthcare News October 24, 2015 – October 30, 2015
  2. 2. © Gyan Research and Analytics Pvt. Ltd., 2015 2  CSIR launches anti-diabetes herbal drug Two laboratories of the Council of Scientific and Industrial Research (CSIR) - National Botanical Research Institute and Central Institute for Medicinal and Aromatic Plant – have jointly launched a scientifically validated anti-diabetes herbal drug 'BGR-34'. The drug is used to treat Type-II diabetes mellitus. It will help to maintain normal blood glucose levels, boost immune system, work as an antioxidant and reduce the probability of complications arising from high blood sugar levels. BGR-34 has natural extracts from four Ayurvedic plants with no side effects. Earlier, the drug was tested on animals and found to be safe and effective. The medicine will be available in the market shortly in the form of tablets, costing INR 500 for 100 tablets.  Arvind Hospital to construct INR 100 crore hospital in Tirupati Aravind Eye Care Hospital will set up an INR 100 crore mega eye hospital in Tirupati for the 10,000 staff of Tirumala-Tirupati Devasthanam (TTD). It will also benefit pilgrims and the local public. The TTD has agreed to allot 7 acres of land owned by it for the eye hospital. TTD would charge INR 7 lakh as annual rental for the land. Aravind is a World Health Organisation collaborating centre for the prevention of blindness and has eye hospitals across 10 locations in Tamil Nadu.  Apollo Hospitals, WWF-India tie up for staff welfare Apollo Hospitals has entered into a one year partnership with the World Wildlife Fund-India to provide immediate medical relief and support to forest guards in case of dire medical emergency. According to the deal, Apollo will provide air ambulance and other emergency medical rescue services in priority areas where the forest departments and WWF-India are active together. For non-emergency cases, the WWF- India and the concerned state forest departments will admit their sick or injured personnel to the nearest Apollo Hospital at their own cost. This partnership will increase morale of the forest staff and empower them.  Lupin launches Calcium Acetate capsules in the US Lupin Pharmaceutical Limted has launched Calcium Acetate capsules in US market. The capsules are the generic version of PhosLo Gelcaps manufactured by Fresenius Medical Care, North America, and is used to treat hyper-phosphatemia in end-stage renal failure. Lupin has marketed the drug after receiving the final approval from US FDA. Investment News  Fortis Healthcare to invest INR 1,500 crore in Punjab Fortis Healthcare announced investments of INR 1,500 crore to double its hospital bed capacity to 1,500 in Punjab. Further, it is adding oncology in each of its hospitals in the state and expanding its Amritsar and Mohali facilities. The company is also building a medical university in the state. Healthcare News October 24, 2015 – October 30, 2015
  3. 3. © Gyan Research and Analytics Pvt. Ltd., 2015 3 Healthcare News October 24, 2015 – October 30, 2015 Weekly Snapshot Source: AIOCD Pharma Softech AWACS Growth in Common Medicine Market in FY2016 (as on September 2015) vis-à-vis FY2015 Type of Medicines Year-on-Year Market Growth in Percent Paracetamol 20.3 Atorvastain 2.9 Probiotic Microbes 19.7 Cefixime 3.6 Pantoprazole 7.5 Montelukast ad Levocetrizine 5.5 Glimepride, Metformin and Pioglitazone 13.7 Vitamin-D 22.3 Hydroquinone, Mometasone and Tretinoin 12.3 Voglibose, Metformin and Glimepride 42.9 Rosuvastatin 22.0 Protein Supplements -2.6 Azithromycin -7.0 Calcium Carbonate and Vitamin D3 18.1
  4. 4. © Gyan Research and Analytics Pvt. Ltd., 2015 4 Market Entry Strategies Market/ Marketing Research Pre-Feasibility, Feasibility & TEV Studies Equity Research & Valuation Economic Intelligence Our Business Practices Business Research Central Delivery Centre BD-9, Sector-1, Salt Lake City Kolkata - 700 064, India Phone: +91-33- 40060084 Corporate Office LG 37-38, Ansal Fortune Arcade, Sector - 18, Noida - 201 301 Delhi NCR, India Phone: +91-120- 2511945 E-mail: Website: Branch Office - Mumbai Branch Office - Bangalore Branch Office - Hyderabad Healthcare News, October 24, 2015 – October 30, 2015